LYON, France--(BUSINESS WIRE)--Theranexus, a clinical-stage biopharmaceutical company, has announced that it is strengthening its management team through the appointment of Julien Veys to the position of Director of Business Development.
Before joining Theranexus, Julien held the same position at the company Trophos, where he played an important role alongside the company’s shareholders when it was sold to Roche laboratories at the beginning of 2015 for 470 million euros.
